Rocket Pharmaceuticals, Inc.

RCKT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$50-$69-$61-$60
Dep. & Amort.$3$3$3$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$11$0$0
Change in WC-$11$9-$6-$1
Other Non-Cash$8-$2$8$12
Operating Cash Flow-$50-$49-$56-$47
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$29-$53-$140-$124
Inv. Sales/Matur.$123$85$82$86
Other Inv. Act.$0$0$0$0
Investing Cash Flow$94$32-$58-$38
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$183
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0$0$0
Financing Cash Flow-$0$0$0$183
Forex Effect$0$0$0$0
Net Chg. in Cash$43-$17-$114$98
Supplemental Information
Beg. Cash$33$51$164$66
End Cash$76$34$50$164
Free Cash Flow-$50-$49-$56-$47